Skip to Content

Medline boosts inventory

Medline boosts inventory

NORTHFIELD, Ill. – Medline has invested an additional $500 million in incremental medical supply inventory to ensure product availability and timely delivery to the healthcare providers it serves.  

The investment, completed at the end of the second quarter of 2022, brings the company’s total on-hand inventory to more than $4 billion and marks another step taken by Medline to help healthcare run better despite continued industry-wide global supply chain challenges. 

“Our inventory management strategy has always been designed with one goal in mind – ensure that the right products are available at the right time to meet the demands of our customers and the patients in their care,” said Jim Pigott, Medline Group president. “This latest investment reflects our ongoing pledge to provide reliable, superior service to healthcare systems across the continuum of care.” 

Since 2018, Medline has invested $2 billion in its U.S. distribution centers, manufacturing capabilities and IT upgrades to further its commitment to delivering superior customer service. 

Throughout the pandemic, Medline has focused on implementing new ideas to address the significant increase in demand for medical supplies nationwide, including expanding its U.S. manufacturing capabilities. The company’s latest North American manufacturing expansion is the addition of Micro-Kill disinfectant wipes to its Hartland, Wis., facility operations, with production beginning in the fourth quarter of 2022.


To comment on this post, please log in to your account or set up an account now.